CXCL9/10-engineered dendritic cells promote T cell activation and enhance immune checkpoint blockade for lung cancer.
Lim RJ, Salehi-Rad R, Tran LM, Oh MS, Dumitras C, Crosson WP, Li R, Patel TS, Man S, Yean CE, Abascal J, Huang Z, Ong SL, Krysan K, Dubinett SM, Liu B.
Lim RJ, et al. Among authors: tran lm.
Cell Rep Med. 2024 Apr 16;5(4):101479. doi: 10.1016/j.xcrm.2024.101479. Epub 2024 Mar 21.
Cell Rep Med. 2024.
PMID: 38518770
Free PMC article.